A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(98 sites)

United States

USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles, California

Rocky Mountain Cancer Center, Denver, Colorado

Georgetown University Medical Center - Lombardi Comprehensive Cancer Center, Washington D.C., District of Columbia

Emory University, Atlanta, Georgia

The University of Iowa, Iowa City, Iowa